John R Moore insider trades

Open-market stock purchases and sales by John R Moore, General Counsel at Edgewise Therapeutics, Inc, from SEC Form 4 filings since Mar 31, 2010.

Recent trades

DateStockTradeValue
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Aug 12, 2026EWTX Edgewise Therapeutics, IncSold$107K
Aug 12, 2026EWTX Edgewise Therapeutics, IncSold$2.6K
Aug 12, 2026EWTX Edgewise Therapeutics, IncSold$4.4K
Aug 12, 2026EWTX Edgewise Therapeutics, IncSold$106K
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—
Aug 12, 2026EWTX Edgewise Therapeutics, IncBought (not open market)—

Companies traded

  • EWTX Edgewise Therapeutics, Inc: 35 sales, last Aug 12, 2026
  • ARRY Array Biopharma Inc: 14 sales, last Apr 1, 2017
  • NVLS Nivalis Therapeutics, Inc: other filings, last Sep 12, 2016

Get free alerts when John R Moore files a new trade →